Analysts have been eager to weigh in on the Healthcare sector with new ratings on GW Pharma (GWPH) and OrthoPediatrics (KIDS).
GW Pharma (GWPH)
Raymond James analyst Danielle Brill maintained a Hold rating on GW Pharma today. The company’s shares closed last Monday at $125.40.
According to TipRanks.com, Brill is a 5-star analyst with an average return of 20.4% and a 59.7% success rate. Brill covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, ACADIA Pharmaceuticals, and Sarepta Therapeutics.
Currently, the analyst consensus on GW Pharma is a Strong Buy with an average price target of $165.56.
See today’s analyst top recommended stocks >>
OrthoPediatrics (KIDS)
In a report released today, Michael Matson from Needham reiterated a Buy rating on OrthoPediatrics, with a price target of $57.00. The company’s shares closed last Monday at $43.75.
According to TipRanks.com, Matson is a 5-star analyst with an average return of 15.6% and a 69.1% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for OrthoPediatrics with a $56.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
